Aim: Reports suggest that hepatocyte replacement by recipient-derived cells is an active phenomenon after allogenic liver transplantation in rats. However, this phenomenon is rarely observed in humans, and further evaluation is necessary to bridge the gap between clinical practice and animal experiment.

Methods: Fifty percent volume of the liver from green fluorescent protein (GFP) transgenic Lewis rats were transplanted into wild-type Dark Agouti (DA) rats, in which GFP negative hepatocytes were considered as host (DA rat)-derived cells. The transplanted liver was observed on whole imaging system and fluorescent microscope 7-10 days after transplantation. As a different method from previous reports, hepatocytes isolated from transplanted livers were cultured, and the expression of GFP was examined.

Results: The sliced liver (2 mm) after allogenic transplantation demonstrated decreased intensity of GFP signals compared with the positive control. The hematoxylin-eosin staining of the section revealed abundant infiltration of inflammatory cells, suggesting an immunological rejection reaction. Large polygonal cells with significantly decreased or negative GFP signals were also demonstrated, which was consistent with the results of previous studies. However, cell culturing demonstrated that none of the examined albumin positive large polygonal cells were host-derived cells. The same results were obtained irrespective of reconstruction of hepatic artery.

Conclusion: Our result implies that rejection reaction does not promote parenchymal replacement by recipient-derived cells, in contrast to previous reports. If so, the phenomena occurring in rats are consistent with clinical observation of liver transplantation in humans.

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.12643DOI Listing

Publication Analysis

Top Keywords

replacement recipient-derived
12
recipient-derived cells
12
liver transplantation
12
hepatocyte replacement
8
cells
8
allogenic liver
8
previous reports
8
gfp signals
8
rejection reaction
8
large polygonal
8

Similar Publications

Application of right ventricular to pulmonary valved conduit in the surgical treatment of congenital heart disease.

Cardiol Young

July 2024

Department of Cardiovascular Surgery, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Fuwai Hospital, Beijing, China.

Article Synopsis
  • Pulmonary valve replacement and right ventricular outflow tract reconstruction in children with congenital heart disease (CHD) have seen advancements, particularly in right ventricular outflow tract technology since the first procedure in 1964.
  • Valved homograft conduits (VHC) offer significant benefits, including better hemodynamics and less need for lifelong anticoagulation, making them ideal for these surgeries, although donor shortages have led to alternatives like polytetrafluoroethylene conduits.
  • Emerging tissue engineering technologies aim to create patient-specific valved conduits using recipient cells, which could eliminate issues like immune rejection and the need for growth adjustments as children develop.
View Article and Find Full Text PDF

Objectives: Tracheal transplantation is an ideal option for the reconstruction of long-segment circumferential tracheal defects. Our group performed the first successful vascularized single-staged tracheal transplantation in January 2021. Although a rigid biocompatible structure is necessary for a functioning tracheal replacement, the importance of ciliated epithelium, which allows for critical mucociliary clearance, is now being appreciated.

View Article and Find Full Text PDF

Allogeneic transplant organs are potentially highly immunogenic. The endothelial cells (ECs) located within the vascular system serve as the primary interface between the recipient's immune system and the donor organ, playing a key role in the alloimmune response. In this study, we investigated the potential use of recipient-derived ECs in a vein recellularization model.

View Article and Find Full Text PDF
Article Synopsis
  • - The study highlights the urgent need for biologically compatible vascular grafts and explores a new method called hydrostatic pressurization under hypoxia (HP/HYP) to create multi-layered vascular walls using human vascular smooth muscle cells.
  • - The HP/HYP method enhances essential cell functions like attachment and collagen production, resulting in the successful creation of robust 10-layered vascular grafts that are strong enough for use.
  • - When implanted in rats, these grafts showed promising results, becoming lined with endothelial cells within a week and remaining functional for five months, which suggests that this technique could advance vascular grafts for treating cardiovascular diseases.
View Article and Find Full Text PDF

The presence of bronchus-associated lymphoid tissue (BALT) in donor lungs has been suggested to accelerate graft rejection after lung transplantation. Although chronic smoke exposure can induce BALT formation, the impact of donor cigarette use on alloimmune responses after lung transplantation is not well understood. Here, we show that smoking-induced BALT in mouse donor lungs contains Foxp3 T cells and undergoes dynamic restructuring after transplantation, including recruitment of recipient-derived leukocytes to areas of pre-existing lymphoid follicles and replacement of graft-resident donor cells.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!